Representative Judy Chu (D-California) recently sold shares of Astrana Health, Inc. NASDAQ: ASTH. In a filing disclosed on August 30th, the Representative disclosed that they had sold between $100,001 and $250,000 in Astrana Health stock on August 19th.
Representative Judy Chu also recently made the following trade(s):
- Purchased $100,001 - $250,000 in shares of Astrana Health NASDAQ: ASTH on 8/19/2025.
Astrana Health Trading Down 3.7%
NASDAQ ASTH traded down $1.18 during mid-day trading on Wednesday, hitting $30.70. The company's stock had a trading volume of 406,263 shares, compared to its average volume of 465,230. Astrana Health, Inc. has a 52-week low of $21.20 and a 52-week high of $63.20. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.59 and a quick ratio of 1.59. The firm has a market capitalization of $1.72 billion, a P/E ratio of 62.67, a price-to-earnings-growth ratio of 0.79 and a beta of 0.85. The stock's fifty day simple moving average is $26.26 and its two-hundred day simple moving average is $28.33.
Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.36 by ($0.17). The firm had revenue of $654.81 million during the quarter, compared to the consensus estimate of $639.13 million. Astrana Health had a net margin of 1.04% and a return on equity of 3.43%. The company's revenue for the quarter was up 34.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.40 earnings per share. Astrana Health has set its Q3 2025 guidance at EPS. Research analysts expect that Astrana Health, Inc. will post 1.15 EPS for the current year.
Wall Street Analysts Forecast Growth
Separately, Zacks Research cut Astrana Health from a "strong-buy" rating to a "strong sell" rating in a report on Monday. Six analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Astrana Health presently has an average rating of "Moderate Buy" and an average target price of $53.29.
Get Our Latest Stock Report on Astrana Health
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of the company. Vanguard Group Inc. increased its stake in shares of Astrana Health by 4.5% in the first quarter. Vanguard Group Inc. now owns 4,898,992 shares of the company's stock valued at $151,918,000 after buying an additional 213,033 shares during the period. 325 Capital LLC lifted its stake in shares of Astrana Health by 30.3% in the 4th quarter. 325 Capital LLC now owns 886,916 shares of the company's stock valued at $27,964,000 after purchasing an additional 206,009 shares during the period. Hotchkis & Wiley Capital Management LLC acquired a new stake in Astrana Health during the first quarter worth approximately $5,564,000. Jacobs Levy Equity Management Inc. lifted its stake in Astrana Health by 211.6% in the first quarter. Jacobs Levy Equity Management Inc. now owns 237,926 shares of the company's stock valued at $7,378,000 after buying an additional 161,580 shares during the period. Finally, AXA S.A. acquired a new stake in shares of Astrana Health during the 2nd quarter worth approximately $3,150,000. 52.77% of the stock is currently owned by institutional investors.
About Representative Chu
Judy Chu (Democratic Party) is a member of the U.S. House, representing California's 28th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.
Chu (Democratic Party) is running for re-election to the U.S. House to represent California's 28th Congressional District. She declared candidacy for the 2026 election.
Judy Chu was born in Los Angeles, California. Chu earned a B.A. from the University of California at Los Angeles in 1974 and a Ph.D. from the California School of Professional Psychology in 1979. Her career experience includes working as a professor with Los Angeles City College and East Los Angeles College. Chu served as the mayor of Monterey Park, California.
Astrana Health Company Profile
(
Get Free Report)
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Featured Articles
Before you consider Astrana Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astrana Health wasn't on the list.
While Astrana Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.